logo

SEQUENOM I(NSDQ:SQNM)
Sequenom Inc. is in the field of industrial genomics. Industrial genomics is the large scale commercial use of the knowledge of DNA variations for improving health, agriculture and livestock. These variations are the differences between individuals, including disease predispositions and variations in drug responses. Single nucleotide polymorphisms are the most common variations. The company has developed the MassArray system, an accurate, cost-effective technology that is capable of high throughput single nucleotide polymorphism analysis at high speeds.
# Employees: 248
Address: 3595 John Hopkins Court,San Diego,CA,USA
Phone: 858 202-9000
Fax: 858-202-9001
Website: www.sequenom.com
Email: acaterina@sequenom.com
Sector: Medical
Industry: MED-BIOMED/GENE
Executive Officers
Harry Stylli (Presi.; C.E.O.)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/10/2010
Mean EPS (Next Qtr): ($0.25)
Mean EPS (Year): ($1.12)
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 9
Shares Performance
Period SQNM Compare to S&P
YTD -84.22 % -86.94 %
4 Weeks -4.57 % -5.60 %
12 Weeks -40.72 % -44.11 %
Shares Information
Analyst Coverage: Y
Avg Volume: 2164838
Shares Outstanding: 61M
Market Cap: $0.19B
52 Week High: $25.54
52 Week Low: $2.76
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 6/2/2006 SQNM split by factor of 0.330
Earnings Performance
EPS Growth in Last Quarter: 30.30 %
EPS Growth in Last Year: -27.78 %
Sales Growth in Last Quarter: 0.57 %
Sales Growth in Last Quarter: -20.31 %
Financials
Qtr Book Value: $2.19
Cash Flow/Share: ($0.01)
Change in Payout Ratio: -0.010
Price/Sales: 4.880
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia